Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial.
De Laere B, Crippa A, Discacciati A, Larsson B, Persson M, Johansson S, D'hondt S, Bergström R, Chellappa V, Mayrhofer M, Banijamali M, Kotsalaynen A, Schelstraete C, Vanwelkenhuyzen JP, Hjälm-Eriksson M, Pettersson L, Ullén A, Lumen N, Enblad G, Thellenberg Karlsson C, Jänes E, Sandzén J, Schatteman P, Nyre Vigmostad M, Olsson M, Ghysel C, Sautois B, De Roock W, Van Bruwaene S, Anden M, Verbiene I, De Maeseneer D, Everaert E, Darras J, Aksnessether BY, Luyten D, Strijbos M, Mortezavi A, Oldenburg J, Ost P, Eklund M, Grönberg H, Lindberg J. De Laere B, et al. Among authors: discacciati a. Nat Med. 2024 Nov;30(11):3291-3302. doi: 10.1038/s41591-024-03204-2. Epub 2024 Aug 20. Nat Med. 2024. PMID: 39164518 Free PMC article. Clinical Trial.
MRI-Targeted or Standard Biopsy in Prostate Cancer Screening.
Eklund M, Jäderling F, Discacciati A, Bergman M, Annerstedt M, Aly M, Glaessgen A, Carlsson S, Grönberg H, Nordström T; STHLM3 consortium. Eklund M, et al. Among authors: discacciati a. N Engl J Med. 2021 Sep 2;385(10):908-920. doi: 10.1056/NEJMoa2100852. Epub 2021 Jul 9. N Engl J Med. 2021. PMID: 34237810 Clinical Trial.
Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial.
Vigneswaran HT, Eklund M, Discacciati A, Nordström T, Hubbard RA, Perlis N, Abern MR, Moreira DM, Eggener S, Yonover P, Chow AK, Watts K, Liss MA, Thoreson GR, Abreu AL, Sonn GA, Palsdottir T, Plym A, Wiklund F, Grönberg H, Murphy AB; SEPTA STHLM3 Study Group. Vigneswaran HT, et al. Among authors: discacciati a. J Clin Oncol. 2024 Nov 10;42(32):3806-3816. doi: 10.1200/JCO.24.00152. Epub 2024 Jul 22. J Clin Oncol. 2024. PMID: 39038251
Author Correction: Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial.
De Laere B, Crippa A, Discacciati A, Larsson B, Persson M, Johansson S, D'hondt S, Bergström R, Chellappa V, Mayrhofer M, Banijamali M, Kotsalaynen A, Schelstraete C, Vanwelkenhuyzen JP, Hjälm-Eriksson M, Pettersson L, Ullén A, Lumen N, Enblad G, Thellenberg Karlsson C, Jänes E, Sandzén J, Schatteman P, Nyre Vigmostad M, Olsson M, Ghysel C, Sautois B, De Roock W, Van Bruwaene S, Anden M, Verbiene I, De Maeseneer D, Everaert E, Darras J, Aksnessether BY, Luyten D, Strijbos M, Mortezavi A, Oldenburg J, Ost P, Eklund M, Grönberg H, Lindberg J. De Laere B, et al. Among authors: discacciati a. Nat Med. 2024 Nov;30(11):3381. doi: 10.1038/s41591-024-03268-0. Nat Med. 2024. PMID: 39198712 Free PMC article. No abstract available.
Anti-CD14 treatment in patients with severe COVID-19: Clinical and biological effects in a Phase 2 randomized open-label adaptive platform clinical trial.
Mabrey FL, Martin TR, Calfee CS, Liu KD, LaCombe B, Brown-Swigart L, Discacciati A, Eklund M, Heckbert SR, Matthay MA, Esserman L, Wurfel MM. Mabrey FL, et al. Among authors: discacciati a. CHEST Crit Care. 2025 Mar;3(1):100117. doi: 10.1016/j.chstcc.2024.100117. Epub 2024 Dec 9. CHEST Crit Care. 2025. PMID: 40462830 Free article.
Data Resource Profile: STHLM0, the Stockholm Prostate Cancer Diagnostics Register.
Abbadi A, Eklund M, Aly M, Clements M, Crippa A, Discacciati A, Björklund A, Lanka V, Micoli C, Lantz A, Grönberg H, Nordström T. Abbadi A, et al. Among authors: discacciati a. Int J Epidemiol. 2025 Apr 12;54(3):dyaf062. doi: 10.1093/ije/dyaf062. Int J Epidemiol. 2025. PMID: 40461103 Free PMC article. No abstract available.
Prognostic Value of the Circulating Tumor DNA Fraction in Metastatic Castration-resistant Prostate Cancer: Results from the ProBio Platform Trial.
Crippa A, Laere B, Discacciati A, Larsson B, Persson M, Johansson S, D'hondt S, Hjälm-Eriksson M, Pettersson L, Enblad G, Ullén A, Lumen N, Karlsson CT, Sandzén J, Jänes E, Ghysel C, Olsson M, Sautois B, Schatteman P, Roock W, Bruwaene SV, Verbiene I, Darras J, Everaert E, Maeseneer D, Anden M, Strijbos M, Luyten D, Mortezavi A, Oldenburg J, Ost P, Lindberg J, Grönberg H, Eklund M; ProBio Investigators. Crippa A, et al. Among authors: discacciati a. Eur Urol Oncol. 2025 Apr 21:S2588-9311(25)00037-9. doi: 10.1016/j.euo.2025.02.002. Online ahead of print. Eur Urol Oncol. 2025. PMID: 40263079 Free article.
Evaluating the performance of existing tools to predict clinically significant prostate cancer in men with indeterminate lesions on biparametric MRI and development of a novel multiplex model: a prospective cohort study.
Abbadi A, Eklund M, Lantz A, Discacciati A, Björnebo L, Palsdottir T, Chandra Engel J, Jäderling F, Falagario U, Grönberg H, Nordström T. Abbadi A, et al. Among authors: discacciati a. EClinicalMedicine. 2025 Apr 3;82:103191. doi: 10.1016/j.eclinm.2025.103191. eCollection 2025 Apr. EClinicalMedicine. 2025. PMID: 40242565 Free PMC article.
91 results